4.4 Article

Incidence and admission rates for severe malaria and their impact on mortality in Africa

期刊

MALARIA JOURNAL
卷 16, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s12936-016-1650-6

关键词

-

资金

  1. Bill and Melinda Gates Foundation [OPP1032350]
  2. Bill and Melinda Gates Foundation [OPP1032350] Funding Source: Bill and Melinda Gates Foundation

向作者/读者索取更多资源

Background: Appropriate treatment of life-threatening Plasmodium falciparum malaria requires in-patient care. Although the proportion of severe cases accessing in-patient care in endemic settings strongly affects overall case fatality rates and thus disease burden, this proportion is generally unknown. At present, estimates of malaria mortality are driven by prevalence or overall clinical incidence data, ignoring differences in case fatality resulting from variations in access. Consequently, the overall impact of preventive interventions on disease burden have not been validly compared with those of improvements in access to case management or its quality. Methods: Using a simulation-based approach, severe malaria admission rates and the subsequent severe malaria disease and mortality rates for 41 malaria endemic countries of sub-Saharan Africa were estimated. Country differences in transmission and health care settings were captured by use of high spatial resolution data on demographics and falciparum malaria prevalence, as well as national level estimates of effective coverage of treatment for uncomplicated malaria. Reported and modelled estimates of cases, admissions and malaria deaths from the World Malaria Report, along with predicted burden from simulations, were combined to provide revised estimates of access to in-patient care and case fatality rates. Results: There is substantial variation between countries' in-patient admission rates and estimated levels of case fatality rates. It was found that for many African countries, most patients admitted for in-patient treatment would not meet strict criteria for severe disease and that for some countries only a small proportion of the total severe cases are admitted. Estimates are highly sensitive to the assumed community case fatality rates. Re-estimation of national level malaria mortality rates suggests that there is substantial burden attributable to inefficient in-patient access and treatment of severe disease. Conclusions: The model-based methods proposed here offer a standardized approach to estimate the numbers of severe malaria cases and deaths based on national level reporting, allowing for coverage of both curative and preventive interventions. This makes possible direct comparisons of the potential benefits of scaling-up either category of interventions. The profound uncertainties around these estimates highlight the need for better data.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, General & Internal

The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China

Guo-Jing Yang, Le-Yuan Shang, Xiao-Nong Zhou, Tamsin E. Lee, Bo Bi, Michael White, Thomas A. Smith, Melissa A. Penny

Summary: This study analyzed historical data of P. vivax incubation periods and relapse patterns in China to understand the effectiveness of the national program in eliminating malaria. The findings showed distinct phenotypes of short- and long-incubation periods for P. vivax parasites, as well as a correlation between sporozoite inoculation and incubation period. A within-host model demonstrated the importance of hypnozoite clearance in controlling malaria epidemics and can inform strategies in other endemic countries.

BMC MEDICINE (2022)

Article Infectious Diseases

Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland

Andrew J. Shattock, Epke A. Le Rutte, Robert P. Dunner, Swapnoleena Sen, Sherrie L. Kelly, Nakul Chitnis, Melissa A. Penny

Summary: The research suggests that even with current NPI measures and rapidly scaled-up vaccine campaigns, a new wave of the epidemic is still predicted. However, a cautious phased relaxation of measures can significantly reduce population morbidity and mortality, while a faster vaccine rollout can offset the impact of such a wave and allow for earlier relaxation of NPIs. Ongoing monitoring and rapid responses to emerging viral variants are crucial for epidemic control.

EPIDEMICS (2022)

Article Materials Science, Multidisciplinary

The competition dynamics of resistant and sensitive infections

T. E. Lee, S. Bonhoeffer, M. A. Penny

Summary: Antimicrobial resistance is a complex health problem, and we have developed a new model to study the dynamics and competition of resistance.

RESULTS IN PHYSICS (2022)

Article Economics

Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease

Katya Galactionova, Paola Salari, Renato Mattli, Yael Rachamin, Rahel Meier, Matthias Schwenkglenks

Summary: The study aimed to evaluate the cost-effectiveness, burden of disease, and budget impact of adding inclisiran to standard-of-care lipid-lowering therapy for secondary cardiovascular prevention in Switzerland. The results showed that inclisiran treatment could provide significant benefits for patients, but it comes with a high cost.

PHARMACOECONOMICS (2022)

Article Medicine, General & Internal

Costs of community-wide mass drug administration and school-based deworming for soil-transmitted helminths: evidence from a randomised controlled trial in Benin, India and Malawi

Chloe Morozoff, Euripide Avokpaho, Saravanakumar Puthupalayam Kaliappan, James Simwanza, Samuel Paul Gideon, Wongani Lungu, Parfait Houngbegnon, Katya Galactionova, Maitreyi Sahu, Khumbo Kalua, Adrian J. F. Luty, Moudachirou Ibikounle, Robin Bailey, Rachel Pullan, Sitara Swarna Rao Ajjampur, Judd Walson, Arianna Rubin Means

Summary: This study compared the costs of community-wide mass drug administration (cMDA) and school-based deworming (SBD). The results showed that cMDA was generally more expensive than SBD, and the costs were sensitive to the number of treatments administered.

BMJ OPEN (2022)

Article Biology

The influence of biological, epidemiological, and treatment factors on the establishment and spread of drug-resistant Plasmodium falciparum

Thiery Masserey, Tamsin Lee, Monica Golumbeanu, Andrew J. Shattock, Sherrie L. Kelly, Ian M. Hastings, Melissa A. Penny, Amy Wesolowski

Summary: Low transmission settings are more likely to develop drug resistance, and the spread of resistance to artemisinin partner drugs depends on the period of low drug concentration. Molecular surveillance and adjusting treatment accordingly are crucial to slow the spread of artemisinin resistance. Additionally, extending parasite exposure to artemisinin derivatives and reducing the selection windows of partner drugs are key to implementing sustainable treatment strategies.
Article Infectious Diseases

Leveraging mathematical models of disease dynamics and machine learning to improve development of novel malaria interventions

Monica Golumbeanu, Guo-Jing Yang, Flavia Camponovo, Erin M. Stuckey, Nicholas Hamon, Mathias Mondy, Sarah Rees, Nakul Chitnis, Ewan Cameron, Melissa A. Penny

Summary: This study presents a quantitative approach using mathematical models and machine learning to guide the development of malaria interventions. The analysis identifies the efficacy, coverage, and duration requirements needed for these interventions to achieve targeted reductions in malaria prevalence.

INFECTIOUS DISEASES OF POVERTY (2022)

Article Infectious Diseases

Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus modelling study

Oliver J. Watson, Bo Gao, Tran Dang Nguyen, Thu Nguyen-Anh Tran, Melissa A. Penny, David L. Smith, Lucy Okell, Ricardo Aguas, Maciej F. Boni

Summary: This study evaluated the impact of high levels of partner-drug resistance on the early emergence of artemisinin-resistant genotypes, finding that higher frequencies of pre-existing partner-drug resistance genotypes lead to earlier establishment of artemisinin resistance. It highlights the importance of continued investment in molecular surveillance of partner-drug resistant genotypes to guide the choice of first-line ACTs.

LANCET MICROBE (2022)

Article Infectious Diseases

Patient variability in the blood-stage dynamics of Plasmodium falciparum captured by clustering historical data

Thiery Masserey, Melissa A. Penny, Tamsin E. Lee

Summary: This study aimed to identify clusters of patients with similar parasitaemia profiles and improve the understanding of within-host variation in future mathematical models. By clustering patients based on key features, the study successfully predicted individual patient parasitaemia profiles and confirmed the personalized immune responses of patients.

MALARIA JOURNAL (2022)

Article Infectious Diseases

COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups

Sherrie L. Kelly, Epke A. Le Rutte, Maximilian Richter, Melissa A. Penny, Andrew J. Shattock

Summary: According to the model, timely administration of COVID-19 vaccine boosters to eligible individuals, prioritizing the most vulnerable, can reduce infections and hospital admissions. These findings provide evidence-based guidance for decision-makers to plan for administering COVID-19 boosters ahead of winter 2022-2023 to mitigate the health burden and stress on the healthcare system.

INFECTIOUS DISEASES AND THERAPY (2022)

Review Parasitology

Measurably recombining malaria parasites

Flavia Camponovo, Caroline O. Buckee, Aimee R. Taylor

Summary: Genomic epidemiology has been a valuable tool for studying viral pathogens and malaria parasites, but the concept of measurably mutating pathogens does not easily apply to sexually recombining parasites. This article introduces the concept of measurably recombining malaria parasites and proposes the development of an inferential framework around recombination to guide practical research in malaria genomic epidemiology. The goal is to fully utilize the potential of genomic epidemiology for sexually recombining pathogens.

TRENDS IN PARASITOLOGY (2023)

Letter Parasitology

Genomic framework for malaria parasites: challenging but necessary

Flavia Camponovo, Caroline O. Buckee, Aimee R. Taylor

TRENDS IN PARASITOLOGY (2023)

Article Multidisciplinary Sciences

Time series analysis of survival and oviposition cycle duration of Anopheles funestus (Giles) in Mozambique

Jacques D. Charlwood, Thomas A. Smith, Ayubo Kampango, Erzelia V. E. Tomas, Nakul Chitnis

Summary: This study estimated the survival rate and oviposition cycle duration of malaria vectors using a time-series analysis approach. The findings suggest that female mosquitoes have lower survival rates compared to males, and that male survival is not influenced by temperature or the use of long-lasting insecticidal nets. However, there is considerable uncertainty in the estimates of oviposition cycle duration.
Article Medicine, Research & Experimental

Modelling to inform next-generation medical interventions for malaria prevention and treatment

Narimane Nekkab, Josephine Malinga, Lydia Braunack-Mayer, Sherrie L. L. Kelly, R. Scott Miller, Melissa A. A. Penny

Summary: Global progress against malaria has stagnated, and there is a need for novel medical interventions to improve protection against infection and disease. The selection of candidates for these interventions should be evidence-based, with input from modeling evidence to link product characteristics with expected public health outcomes and inform decision-making.

COMMUNICATIONS MEDICINE (2023)

Article Medicine, Research & Experimental

Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden

Epke A. Le Rutte, Andrew J. Shattock, Nakul Chitnis, Sherrie L. Kelly, Melissa A. Penny

Summary: This study shows that the infectivity of future variants is the primary determinant of whether it will become most common, but this increased infectivity does not always lead to an increased public health burden. Increasing vaccination, especially for highly infectious and severe variants that the immune system responds to, is projected to have the biggest public health benefit.

COMMUNICATIONS MEDICINE (2022)

暂无数据